Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire

التفاصيل البيبلوغرافية
العنوان: Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire
المؤلفون: Kristof Chwalisz, Mary Kay Margolis, Ahmed M. Soliman, Karin S. Coyne, Christine L. Thompson
المصدر: Current medical research and opinion. 33(2)
سنة النشر: 2016
مصطلحات موضوعية: Adult, medicine.medical_specialty, Psychometrics, Uterine fibroids, Patient demographics, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Internal consistency, Surveys and Questionnaires, Medicine, Humans, 030212 general & internal medicine, Menorrhagia, Retrospective Studies, Health related quality of life, 030219 obstetrics & reproductive medicine, Descriptive statistics, Recall, Leiomyoma, business.industry, Reproducibility of Results, General Medicine, Middle Aged, medicine.disease, humanities, Menstrual bleeding, Physical therapy, Quality of Life, Female, business
الوصف: To assess the psychometric performance of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire (UFS-QoL), a patient measure of the severity of uterine fibroid (UF) symptoms and their impact on health-related quality of life (HRQL).This was a retrospective analysis of phase 2a data from pre-menopausal women with heavy menstrual bleeding associated with UF. Participants completed the UFS-QoL at Baseline, Treatment Month 3, and Follow-up Month 3 and a daily diary with a Menstrual Bleeding Scale and the UF Daily Symptom Scale throughout the study duration. Descriptive statistics were performed on patient demographic characteristics; analyses were conducted to assess the internal consistency reliability, validity, and responsiveness of the UFS-QoL 4 week recall version.A total of 271 women were enrolled with a mean age of 41.8 years; 74% were black. The UFS-QoL demonstrated excellent internal consistency reliability, with Cronbach's alpha coefficient values0.70 for each subscale at each study visit. Results indicated good concurrent validity with the UF Daily Symptom Scale items. The women with amenorrhea at Treatment Month 3 had significantly better scores on all UFS-QoL subscales and HRQL Total than women with menstrual bleeding, indicating acceptable discriminant validity. Mean subscale change scores from Baseline to Treatment Month 3 were 19.2 to 39.8. Effect sizes were moderate to large (0.53 to 1.86), demonstrating responsiveness to change.As this study is a post hoc validation of the 4 week recall UFS-QOL, it is limited to the clinical trial data available and does not include a direct comparison to the 3 month recall version of UFS-QOL.The 4 week recall version of the UFS-QoL demonstrated good internal consistency reliability, concurrent validity, and responsiveness and is psychometrically comparable to the original 3 month recall UFS-QoL.Data from a phase 2a, cohort design proof of concept study (trial M12-663); ClinicalTrials.gov identifier NCT01441635. Date of Registration: 6 September 2011.
تدمد: 1473-4877
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e91c036081c5f8f2fe425261345252ec
https://pubmed.ncbi.nlm.nih.gov/27733082
رقم الأكسشن: edsair.doi.dedup.....e91c036081c5f8f2fe425261345252ec
قاعدة البيانات: OpenAIRE